These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 19614642)

  • 1. New pharmacological strategies for the treatment of atrial fibrillation.
    Burashnikov A; Antzelevitch C
    Ann Noninvasive Electrocardiol; 2009 Jul; 14(3):290-300. PubMed ID: 19614642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pharmacological targets and treatments for atrial fibrillation.
    Carlsson L; Duker G; Jacobson I
    Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in atrial antiarrhythmic drug therapy.
    Burashnikov A; Antzelevitch C
    Nat Rev Cardiol; 2010 Mar; 7(3):139-48. PubMed ID: 20179721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pharmacological targets for the rhythm control management of atrial fibrillation.
    Burashnikov A; Antzelevitch C
    Pharmacol Ther; 2011 Dec; 132(3):300-13. PubMed ID: 21867730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approaches for pharmacological management of atrial fibrillation.
    Ehrlich JR; Nattel S
    Drugs; 2009; 69(7):757-74. PubMed ID: 19441867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic therapy in atrial fibrillation.
    Ravens U
    Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches.
    Savelieva I; Camm J
    Europace; 2008 Jun; 10(6):647-65. PubMed ID: 18515286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anti-arrhythmic drugs for atrial fibrillation management.
    Ehrlich JR; Nattel S; Hohnloser SH
    Curr Vasc Pharmacol; 2007 Jul; 5(3):185-95. PubMed ID: 17627562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pharmacological approaches to atrial fibrillation.
    Milnes JT; Madge DJ; Ford JW
    Drug Discov Today; 2012 Jul; 17(13-14):654-9. PubMed ID: 22370250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging pharmacotherapies for the treatment of atrial fibrillation.
    Capucci A; Cipolletta L; Guerra F; Giannini I
    Expert Opin Emerg Drugs; 2018 Mar; 23(1):25-36. PubMed ID: 29508636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
    Aguilar M; Nattel S
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological approaches in the treatment of atrial fibrillation.
    Tamargo J; Caballero R; Delpón E
    Curr Med Chem; 2004 Jan; 11(1):13-28. PubMed ID: 14754423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation.
    Dobrev D
    J Interv Card Electrophysiol; 2008 Aug; 22(2):107-10. PubMed ID: 18330686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of I
    Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
    Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.
    Nattel S; Khairy P; Roy D; Thibault B; Guerra P; Talajic M; Dubuc M
    Drugs; 2002; 62(16):2377-97. PubMed ID: 12396229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
    Antzelevitch C; Burashnikov A
    J Electrocardiol; 2009; 42(6):543-8. PubMed ID: 19698954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac K
    Staudacher I; Seehausen S; Illg C; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
    Prog Biophys Mol Biol; 2019 Jul; 144():128-138. PubMed ID: 31182191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drug therapy for atrial fibrillation: focus on atrial selectivity and safety.
    Li D; Sun H; Levesque P
    Cardiovasc Hematol Agents Med Chem; 2009 Jan; 7(1):64-75. PubMed ID: 19149545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.